The Role of LncRNAs in Pulmonary Fibrosis, 2017-2021, National Institutes of Health/NHLBI, R01HL135152, $1,496,000
MicroRNA-193b regulation of influenza virus replication, 2016 - 2018, National Institutes of Health/NIAID, R21AI121591, $402,325
Stem cell-based therapy of influenza virus infection, 2016 - 2017, Oklahoma Center for Adult Stem Cell Research, $168,000
RNA_seq analysis of α7 nicotinic acetylcholine receptor activated lung epithelial cells, 2016-2017, CVHS, Oklahoma State University, $11,640.
Purinergic P2X7 Receptor as a Pro-inflammatory Molecule, 2014 - 2017, Oklahoma Center for the Advancement of Science and Technology, Oklahoma Health Research Grant, HR14-060, $135,000
Oklahoma Center for Respiratory and Infectious Diseases (CoBRE, Center of Biomedical Research Excellence), 2013 - 2018, National Institutes of Health/NIGMS, P20GM103648, $11,231,206
miR-101 Control of Pulmonary Fibrosis, 2013 - 2018, National Institutes of Health/NHLBI, R01HL116876, $1,434,655
Completed
Mesenchymal Stem Cell Exosomes for Treating COPD, 2015 - 2016, Oklahoma Center for Adult Stem Cell Research, $168,000
Mesenchymal stem cell-derived lung epithelial cells for COPD therapy, 2014 - 2015, Oklahoma Center for Adult Stem Cell Research, $168,000
Interdisciplinary Program in Regenerative Medicine at OSU, 2013 - 2014, OSU Planning Grants for Establishing Creative Interdisciplinary Programs, $34,900
Regulation of Influenza Virus Replication, 2013 - 2014, Research Advisory Committee, CVHS, Oklahoma State University, $15,000
MicroRNA Technology, 2012 - 2014, Technology Business Development Program (TBDP), Oklahoma State University, $20,000
MicroRNA-mediated Differentiation of Induced Pluripotent Stem Cells into Alveolar Epithelial Type II cells: Mechanisms and Therapy for COPD, 2012-2013, Oklahoma Center for Adult Stem Cell Research, Oklahoma Center for Adult Stem Cell Research, $112,000
A Shared Equipment for Creating a Lung Disease Model to Test Efficacy of Adult Stem Cell Therapy, 2012, Oklahoma Center for Adult Stem Cell Research, $42,560
Regulation of VAMP-2 in Alveolar Type II Cells by MicroRNA-206, 2011 - 2013, American Heart Association, South Central Affiliate, #11GRNT7450069, $140,000
Cell-based Therapy of COPD Using Induced Pluripotent Stem Cell-Derived Alveolar Epithelial Type II cells, 2011-2012, Oklahoma Center for Adult Stem Cell Research, $72,800
Development of MicroRNA Expression Library, 2010 - 2012, Oklahoma Center for the Advancement of Science and Technology, Oklahoma Applied Research Support (AR101.1-037), $90,000
Reprogramming of Adult Lung Cells for Cell-Based Therapy, 2010-2011, Oklahoma Center for Adult Stem Cell Research, $72,800
Purchase of Shared Equipment for Testing Efficacy of Adult Stem Cell Therapy, 2010 - 2011, Oklahoma Center for Adult Stem Cell Research, $62,638
Paracine Regulation of Lung Surfactant Secretion, 2010, Research Advisory Committee, Center for Veterinary Health Sciences, OSU, $15,000
MicroRNAs and Bovine Respiratory Disease, 2009 - 2012, U.S. Department of Agriculture 2009-035505-05855, $225,000
Role of MicroRNAs in Bronchopulmonary Dysplasia, 2009 - 2011, National Institutes of Health/NHLBI, R21 HL087884, $402,600
MicroRNA Expression Profiling in Idiopathic Pulmonary Fibrosis, 2009 - 2011, National Institutes of Health/NHLBI R03 HL095383, $147,700
Molecular Signaling in Alveolar Epithelial Cells, 2009, Research Advisory Committee, Center for Veterinary Health Sciences, OSU, $20,000
Role of MicroRNAs in Bronchopulmonary Dysplasia, 2008 - 2009, Oklahoma Center for the Advancement of Science and Technology, Oklahoma Health Research Grant, HR08-064, $45,000
Mechanisms of Alveolar Fluid Transport, 2006 - 2010, National Institutes of Health/NHLBI, R01 HL083188, $1,423,125
Biotechnology, Gene Silencing using RNA Interference, 2006 - 2007, Technology and Business Assessment Group (TBAG), Oklahoma State University, $30,000
GABA Receptor and Pulmonary Fluid Transport, 2005 - 2008, March of Dimes Birth Defects, 6FY-05-76, $258,075
Molecular Mechanisms of Lung Surfactant Secretion, 2004 - 2008, National Institutes of Health/NHLBI R01, HL-052146, $1,214,400
Mechanisms of Alveolar Epithelial Cell Differentiation, 2003 - 2007, National Institutes of Health/NHLBI, R01 HL-071628, $1,214,400
Postdoctoral Research Supplements for Underrepresented Minorities (Marcia Davita Howard), 2002 - 2004, National Institutes of Health/NHLBI, R01 HL-52146S1, $116,148
Lung Epithelial Cell Differentiation and Oxidative Stress, 2002 - 2004, American Heart Association, Heartland Affiliate, Grant-in-Aid, 0255992Z, $110,000
Arsenic-induced Changes of Gene Expression in Lung cells, 2002 - 2003, Centers for Disease Control and Prevention, $20,000
Regulation of Lung Surfactant Secretion by Nitric Oxide, 2001 - 2004, Oklahoma Center for the Advancement of Science and Technology, Oklahoma Health Research Grant, HR01-093, $135,000
Regulation of Bovine Annexin II by Phosphorylation, 2001 - 2003, Oklahoma Agricultural Experiment Station, $ 43,695
Molecular Mechanisms of Lung Surfactant Secretion, 2000 - 2004, National Institutes of Health/NHLBI, R01 HL-52146, 6.3 percentile, $922,829
Graduate Research Assistants with Disabilities Supplement (William H. Rowan), 1998 - 2002, National Institutes of Health/NHLBI, R01 HL-52146S, $141,696
Annexins and Lung Surfactant Secretion, 1995 - 2000, National Institutes of Health/NHLBI, R29, 1.0 percentile, R01 HL-52146, $485,772